Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real-world study

Affiliations

¹ Department of Medicine Surgery and Dentistry, "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
² Dermatology Unit, University of G. D'Annunzio, Chieti, Italy.
³ Dermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy.
⁴ Dermatology Unit, "G. Rummo" Hospital, Benevento, Italy.
⁵ Dermatology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
⁶ Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Section of Dermatology, University of Messina, Messina, Italy.
⁷ Dermatology Unit, San Giovanni di Dio e Ruggi D'Aragona University Hospital, Salerno, Italy.
⁸ Section of Dermatology, Department of Clinical, Medicine and Surgery, University of Naples Federico II, Naples, Italy.
⁹ Department of Dermatology, University of Catania, Catania, Italy.
¹⁰ Dermatology and Dermosurgery, "San Giuseppe Moscati" National Hospital (AORN), Contrada Amoretta, Avellino, Italy.
¹¹ Dermatology Unit, A. Tortora Hospital, Pagani, Salerno, Italy.

Annunziata Raimondo et al. J Eur Acad Dermatol Venereol. 2025 Mar.

. 2025 Mar;39(3):e287-e289.

doi: 10.1111/jdv.20341. Epub 2024 Sep 13.

¹ Department of Medicine Surgery and Dentistry, "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
² Dermatology Unit, University of G. D'Annunzio, Chieti, Italy.
³ Dermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy.
⁴ Dermatology Unit, "G. Rummo" Hospital, Benevento, Italy.
⁵ Dermatology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
⁶ Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Section of Dermatology, University of Messina, Messina, Italy.
⁷ Dermatology Unit, San Giovanni di Dio e Ruggi D'Aragona University Hospital, Salerno, Italy.
⁸ Section of Dermatology, Department of Clinical, Medicine and Surgery, University of Naples Federico II, Naples, Italy.
⁹ Department of Dermatology, University of Catania, Catania, Italy.
¹⁰ Dermatology and Dermosurgery, "San Giuseppe Moscati" National Hospital (AORN), Contrada Amoretta, Avellino, Italy.
¹¹ Dermatology Unit, A. Tortora Hospital, Pagani, Salerno, Italy.

No abstract available

References

1. Gisondi P, Fargnoli MC, Amerio P, Argenziano G, Bardazzi F, Bianchi L, et al. Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasis. Ital J Dermatol Venerol. 2022;157(1):1–78. https://doi.org/10.23736/S2784‐8671.21.07132‐2
1. Zhang Z, Fan W, Yang G, Xu Z, Wang J, Cheng Q, et al. Risk of tuberculosis in patients treated with TNF‐α antagonists: a systematic review and meta‐analysis of randomised controlled trials. BMJ Open. 2017;7(3):e012567. https://doi.org/10.1136/bmjopen‐2016‐012567
1. Benhadou F, Dirix V, Domont F, Willaert F, Van Praet A, Locht C, et al. Tuberculosis risk stratification of psoriatic patients before anti‐TNF‐α treatment. Front Immunol. 2021;12:672894. https://doi.org/10.3389/fimmu.2021.672894
1. Torres T, Chiricozzi A, Puig L, Lé AM, Marzano AV, Dapavo P, et al. Treatment of psoriasis patients with latent tuberculosis using IL‐17 and IL‐23 inhibitors: a retrospective, multinational, multicentre study. Am J Clin Dermatol. 2024;25(2):333–342. https://doi.org/10.1007/s40257‐024‐00845‐4
1. Ibba L, Gargiulo L, Vignoli CA, Fiorillo G, Valenti M, Costanzo A, et al. Safety of anti‐IL‐23 drugs in patients with moderate‐to‐severe plaque psoriasis and previous tuberculosis infection: a monocentric retrospective study. J Dermatolog Treat. 2023;34(1):2241585. https://doi.org/10.1080/09546634.2023.2241585